Video summary
Does TRT Cause Hair Loss? Gel vs Injections vs Enclomiphene
Main summary
Key takeaways
Key wellness / self-care / productivity takeaways (from the video)
-
Don’t focus only on “how high testosterone gets”—focus on DHT.
- Hair loss (male pattern baldness) is driven by DHT (dihydrotestosterone) binding to androgen receptors in genetically sensitive scalp follicles.
- This binding gradually shrinks follicles and shortens the growth phase.
- The key biochemical lever is 5-alpha reductase, the enzyme converting testosterone → DHT.
-
Compare TRT methods by where/how they increase DHT
-
Topical testosterone gel/cream = worst for hair
- Skin contains dense 5-alpha reductase type II, so topical testosterone converts to DHT locally before it reaches the bloodstream.
- Reported trial example: topical testosterone increased DHT from ~15 ng/dL to ~51.6 (about 2.5× higher DHT vs enclomiphene at similar testosterone levels).
-
Injections = better than gels, but not “clean”
- Intramuscular injection avoids the skin enzyme conversion step (skips the “skin depot”).
- Still imperfect because it introduces exogenous testosterone, which your body can’t regulate normally and can suppress natural production.
- Reported pooled data example: DHT rose to ~2.2× baseline for intramuscular vs ~5.5× for transdermal (for comparable testosterone gains).
-
Enclomiphene = best of the three for hair (mechanistically)
- Enclomiphene does not contain testosterone; it works upstream by blocking estrogen signaling in the hypothalamus/pituitary.
- This increases LH/FSH, which increases your body’s own testosterone production.
- Because testosterone is produced through your regulated system, the increase in DHT is described as more proportional and avoids the “topical skin conversion penalty.”
-
-
Watch the “DHT:testosterone ratio” concept
- The video emphasizes the relevant hair-risk metric may be the ratio of DHT to testosterone, not absolute DHT alone.
- Reported trial example: a 25 mg clomiphene group raised DHT (statistically significant), while the DHT:testosterone ratio change was ~zero in that dataset.
- A counterpoint is noted: hair follicles might respond to absolute DHT concentration instead of the ratio—this hasn’t been directly settled in scalp hair-count studies.
-
Evidence limitations (important self-care reality check)
- No trials directly counted hair loss over enough time.
- Reported concern: among registered enclomiphene trials, 0 hair loss events were reported, but:
- trials used low reporting thresholds (e.g., 3%/5%), and
- observation windows were around 12–13 months, while male pattern baldness unfolds over years.
-
Ranking (worst → best for hair, per mechanism + hormone data)
- Testosterone gels/creams
- Injections
- Enclomiphene
Caveat: this ranking is based on hormone measurements and mechanism, not long-term hair-count outcomes.
- Personal protocol mentioned (example only, not a prescription)
- The presenter says they use:
- TRT + enclomiphene together (aim: keep higher testosterone while maintaining natural production to some extent)
- Enhanced Labs Organ Support containing saw palmetto, described as lowering DHT
- Note: this is framed as the presenter’s experience.
- The presenter says they use:
Presenters / sources
- Presenter: The video speaker (not named in the subtitles)
- Sources cited by type:
- Randomized trials comparing gel vs injections vs enclomiphene
- A 2025 meta-analysis on enclomiphene/clomiphene-class effects on DHT
- Independent researchers pooling randomized data
- Up to eight registered enclomiphene trials (details not individually named in the subtitles)
- Brands mentioned: Enhanced Labs (product name: Organ Support)
Rate this summary
Your feedback will help improve summaries.
Improve this summary
Reprocess with a stronger model when the summary feels incomplete or inaccurate.
Translate summary in another language
Ask questions to this video
Chat for follow-up questions, clarifications, and source-backed answers.